| | Business Summary | | VISX,
Incorporated
is
engaged
in
the
development
of
proprietary
technologies
and
systems
for
laser
vision
correction
(LVC).
LVC
relies
on
a
computerized
laser
to
treat
nearsightedness,
astigmatism
and
farsightedness
with
the
goal
of
eliminating
or
reducing
reliance
on
eyeglasses
and
contact
lenses.
LVC
includes
LASIK
and
PhotoRefractive
Keratectomy.
The
VISX
Excimer
Laser
System
ablates,
or
removes,
submicron
layers
of
tissue
from
the
surface
of
the
cornea
to
reshape
the
eye,
thereby
improving
vision.
The
VISX
STAR
S3
ActiveTrak
Excimer
Laser
employs
a
three-dimensional
eye
tracker
that
is
capable
of
following
all
eye
movements
during
the
procedure,
ensuring
precisely
centered
ablations.
A
secondary
market
for
the
VISX
System
is
the
treatment
of
corneal
pathologies.
In
May
2000,
VISX
received
510(k)
clearance
from
the
FDA
of
the
WaveScan
Wavefront
System,
which
uses
wavefront
technology
to
diagnose
refractive
errors
of
the
eye. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | VISX,
Incorporated
designs
and
develops
proprietary
technology
and
systems
for
laser
vision
correction.
For
the
six
months
ended
6/30/01,
total
revenues
decreased
10%
to
$101
million.
Net
income
decreased
92%
to
$1.9
million.
Revenues
reflect
a
decrease
in
U.S.
customer
purchases
of
VisionKey
cards
and
a
reduction
in
licensing
fees.
Net
income
also
suffered
from
$37.8
million
in
litigation
settlement
charges
and
fees
related
to
claims
involving
Pillar
Point
Partners. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Mark Logan, 62
Chairman | $512K | $46K | Elizabeth Davila, 56
Pres,
CEO, Director | 368K | -- | Timothy Maier, 52
CFO,
Exec. VP, Treasurer | 265K | -- | Douglas Post, 49
Exec.
VP - Operations | 241K | 534K | Derek Bertocci, 47
VP
and Controller | -- | -- | | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/e/eye.gif)